Other Events ·
Veru Inc. entered into a clinical supply agreement with Novo Nordisk A/S to support its Phase 2b PLATEAU clinical…
VERUVeru Inc.
Veru Inc. entered into a clinical supply agreement with Novo Nordisk A/S to support its Phase 2b PLATEAU clinical study evaluating the combination of enobosarm and Wegovy in older adults with obesity. Under the terms, Novo Nordisk will provide Wegovy at no charge for the study, while Veru grants Novo Nordisk a right of first negotiation for future combination development of enobosarm with Novo Nordisk GLP-1 products.